Published in Brain Res on December 24, 1990
Glutamate transporter subtype 1 (GLT-1) activator ceftriaxone attenuates amphetamine-induced hyperactivity and behavioral sensitization in rats. Drug Alcohol Depend (2011) 1.02
Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists. Br J Pharmacol (1994) 0.88
Effects of dizocilpine [(+)-MK-801] on the expression of associative and non-associative sensitization to D-amphetamine. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.76
Correlation between nerve terminal size and transmitter release at the neuromuscular junction of the frog. J Physiol (1971) 4.25
Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci (1989) 1.49
Barbiturate-induced transmitter release at a frog neuromuscular junction. Br J Pharmacol (1973) 1.28
Severe ocular trauma caused by an ostrich. Br J Ophthalmol (2005) 1.19
Orbital melanoma presenting as orbital cellulitis: a clinicopathologic report. Ophthal Plast Reconstr Surg (1998) 1.17
The cannabinoids as potential antiepileptics. J Clin Pharmacol (1982) 0.99
Effects of muscle stretch on transmitter release at end-plates of rat diaphragm and frog sartorius muscle. J Physiol (1973) 0.98
Some properties of the denervated anterior gracilis muscle of the rat. Br J Pharmacol (1969) 0.97
Anticonvulsant properties of delta 9-tetrahydrocannabinol and other cannabinoids. Life Sci (1974) 0.97
Development of early choroidal neovascular membrane in a young myope after LASIK. Eur J Ophthalmol (2007) 0.96
The anticonvulsant activity of cannabidiol and cannabinol. Life Sci (1973) 0.93
Prevalence of hip fracture risk factors in women aged 70 years and over. QJM (2000) 0.90
Modulation of stimulation-evoked release of newly formed acetylcholine from mouse hemidiaphragm preparation. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.90
Subacute cannabinoid treatment: anticonvulsant activity and withdrawal excitability in mice. Br J Pharmacol (1980) 0.89
Cocaine behavioral sensitization and the excitatory amino acids. Psychopharmacology (Berl) (1994) 0.89
DNQX blockade of amphetamine behavioral sensitization. Brain Res (1991) 0.88
The role of the frontal cortex in the mouse in behavioral sensitization to amphetamine. Brain Res (1997) 0.87
Calcium channel blockers and behavioral sensitization. Life Sci (1991) 0.86
Blockade of behavioral sensitization to cocaine and amphetamine by inhibitors of protein synthesis. Brain Res (1993) 0.84
Excitatory amino acids and the actions of cocaine. Brain Res (1992) 0.84
The role of dopamine in the mouse frontal cortex: a new hypothesis of behavioral sensitization to amphetamine and cocaine. Pharmacol Biochem Behav (1998) 0.83
A study of the development of tolerance to an anticonvulsant effect of delta9-tetrahydrocannabinol and cannabidiol. Res Commun Chem Pathol Pharmacol (1974) 0.83
The role of dopamine and GABA in the frontal cortex of mice in modulating a motor-stimulant effect of amphetamine and cocaine. Pharmacol Biochem Behav (1998) 0.83
Tubocurarine and pancuronium inhibit evoked release of acetylcholine from the mouse hemidiaphragm preparation. Br J Anaesth (1987) 0.83
Anticonvulsant properties of cannabidiol. Res Commun Chem Pathol Pharmacol (1974) 0.82
An electrophysiological analysis of the anticonvulsant action of cannabidiol on limbic seizures in conscious rats. Epilepsia (1979) 0.82
Excitatory and depressant effects of delta 9-tetrahydrocannabinol and cannabidiol on cortical evoked responses in the conscious rat. Psychopharmacology (Berl) (1981) 0.82
The dopaminergic, glutamatergic, GABAergic bases for the action of amphetamine and cocaine. Brain Res (1995) 0.81
Influence of delta9-tetrahydrocannabinol and cannabidiol on photically evoked after-discharge potentials. Psychopharmacology (Berl) (1977) 0.81
Some effects of vinblastine and colchicine on neuromuscular transmission. Brain Res (1973) 0.81
A novel nicotinic-cholinergic role in behavioral sensitization to amphetamine-induced stereotypy in mice. Brain Res (1996) 0.80
Central excitatory properties of delta 9-tetrahydrocannabinol and its metabolites in iron-induced epileptic rats. Neuropharmacology (1982) 0.80
A study of the relative anticonvulsant and toxic activities of delta9-tetrahydrocannabinol and its congeners. Res Commun Chem Pathol Pharmacol (1974) 0.80
The influence of delta9-tetrahydrocannabinol, cannabinol and cannabidiol on tissue oxygen consumption. Res Commun Chem Pathol Pharmacol (1975) 0.80
Electrophysiologic properties of the cannabinoids. J Clin Pharmacol (1982) 0.80
The influence of cannabidiol and delta 9-tetrahydrocannabinol on cobalt epilepsy in rats. Epilepsia (1979) 0.80
Cannabis and epilepsy. Adv Biosci (1980) 0.80
Myoneural effects of pethidine and droperidol. Br J Anaesth (1984) 0.79
The role of the striatum in the mouse in behavioral sensitization to amphetamine. Pharmacol Biochem Behav (1997) 0.79
Prolonged CNS hyperexcitability in mice after a single exposure to delta-9-tetrahydrocannabinol. Neuropharmacology (1986) 0.78
Effects of cannabinoids on the perfused rat heart. Res Commun Chem Pathol Pharmacol (1976) 0.78
Phencyclidine and behavior: I. Sensory-motor function, activity level, taste aversion and water intake. Pharmacol Biochem Behav (1981) 0.77
Chemical composition of upper renal tract calculi in Multan. J Pak Med Assoc (2000) 0.77
Cannabidiol-caused depression of spinal motoneuron responses in cats. Pharmacol Biochem Behav (1986) 0.77
Different cannabinoids exhibit different pharmacological and toxicological properties. NIDA Res Monogr (1987) 0.77
Kindling-like effect induced by repeated corneal electroshock in mice. Epilepsia (1982) 0.77
Calcium channel blockers and excitatory amino acids. Brain Res (1991) 0.76
Effects of delta-9-tetrahydrocannabinol, 11-hydroxy-delta-9-tetrahydrocannabinol and cannabidiol on neuromuscular transmission in the frog. Neuropharmacology (1986) 0.76
The pharmacokinetic fate of cannabidiol and its relationship to barbiturate sleep time. Biochem Pharmacol (1979) 0.76
A new short-acting non-depolarizing muscle relaxant (SZ1677) without cardiovascular side-effects. Acta Anaesthesiol Scand (2003) 0.76
A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine. Brain Res (1994) 0.76
Influence of anticonvulsant cannabinoids on posttetanic potentiation at isolated bullfrog ganglia. Life Sci (1975) 0.76
Posttrial electrical stimulation of the dorsal hippocampus facilitates acquisition of the nictitating membrane response. Behav Neurosci (1983) 0.76
Comparative behavioral sensitization to stereotypy by direct and indirect dopamine agonists in CF-1 mice. Psychopharmacology (Berl) (1996) 0.76
Interaction between delta-9-tetrahydrocannabinol and kindling by electrical and chemical stimuli in mice. Neuropharmacology (1984) 0.75
Species variation in the site and mechanism of the neuromuscular effects of diadonium in rodents. Anesth Analg (1989) 0.75
Direct evidence that pancuronium and gallamine enhance the release of norepinephrine from the atrial sympathetic nerve by inhibiting prejunctional muscarinic receptors. J Auton Nerv Syst (1987) 0.75
Rewarding periaqueductal gray stimulation disrupts long-term memory for passive avoidance learning. Behav Neural Biol (1980) 0.75
Characteristics of "reverse tolerance" to amphetamine-induced locomotor stimulation in mice. Neuropharmacology (1988) 0.75
Inhibition of mobilization of acetylcholine: the weak link in neuromuscular transmission during partial neuromuscular block with d-tubocurarine. Anesthesiology (1989) 0.75
Reverse tolerance to amphetamine evokes reverse tolerance to 5-hydroxytryptophan. Life Sci (1990) 0.75
Pentylenetetrazol kindling in mice. Neuropharmacology (1989) 0.75
The pre- and postjunctional components of the neuromuscular effect of antibiotics. J Anesth (1991) 0.75
Effects of delta 9-tetrahydrocannabinol on cat spinal motoneurons. Brain Res (1983) 0.75
Proconvulsant and anticonvulsant effects in mice of acute and chronic treatment with cocaine. Neuropharmacology (1989) 0.75
Anticonvulsant activity of delta9-tetrahydrocannabilol and its 11-hydroxy and 8alpha, 11-dihydroxy metabolites in the frog. Res Commun Chem Pathol Pharmacol (1974) 0.75
Whole-cell voltage-clamp study of sodium current in neuroblastoma cells: effects of inhibition of neurite outgrowth by colchicine. Brain Res (1990) 0.75
Naloxone-induced augmentation of the photically evoked afterdischarge in conscious rats. Brain Res Bull (1984) 0.75
In vitro comparison of the neuromuscular antinicotinic and intestinal antimuscarinic effects of different nondepolarizing muscle relaxants. Arch Int Pharmacodyn Ther (1989) 0.75
Influence of different barbiturate anesthetics on delta-9-tetrahydrocannabinol effects on spinal monosynaptic reflexes. Life Sci (1983) 0.75
Evidence for the release and depletion of the postsynaptic inhibitory transmitter by pilocarpine. Arch Int Pharmacodyn Ther (1968) 0.75
Influence of 11-hydroxy-delta-9-tetrahydrocannabinol on spinal motoneurons in cat. Neuropharmacology (1984) 0.75
Acid precipitation of liver microscomes for the study of drug metabolism. Arch Int Pharmacodyn Ther (1968) 0.75
Knowledge, attitudes and practices of patients and their attendants visiting a family physician's clinic. J Pak Med Assoc (1992) 0.75
Influence of 22-day treatment on the anticonvulsant properties of cannabinoids. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.75
Naloxone-induced epileptogenesis has brain-site specificity in rats. Neuropharmacology (1982) 0.75
Changes in CNS sensitivity to cannabinoids with repeated treatment: tolerance and auxoesthesia. NIDA Res Monogr (1984) 0.75
Cannabinoid-induced enhancement and depression of cat monosynaptic reflexes. Neuropharmacology (1981) 0.75